ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Antioxidant treatment could halt neurodegeneration in early Parkinson's

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

 
Print Page
Email Article

Gene Transfer Reduces Levels of Key Alzheimer's Disease Protein

  [ 41 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 26, 2003


A molecule that naturally degrades a protein linked to Alzheimer's disease appears to reduce the levels of that protein by nearly 50 percent when delivered by gene therapy, researchers at the Salk Institute and University of California, San Diego have found in collaboration with researchers at the University of Kentucky. The findings appear in the March 15 issue of the Journal of Neuroscience.

The study indicates that gene therapy may provide an effective way to treat Alzheimer's by producing – in the body – a molecule that reduces naturally the accumulation of the protein beta-amyloid. Beta-amyloid constitutes the plaques seen in the brains of people who have died from the disease.

Robert Marr, working under Inder Verma at the Salk Institute in collaboration with the laboratories of Fred H. Gage at the Salk Institute and Eliezer Masliah at UCSD, used a modified version of the HIV virus to transfer a gene called neprilysin to neurons of transgenic mice producing human beta-amyloid, which lowered levels of the harmful protein to half that found in untreated animals. Furthermore, treatment was shown to eliminate the degeneration that was caused by buildups of beta-amyloid. The study marks the first time researchers could directly show that neprilysin inhibits beta-amyloid accumulation in animals.

"This study supports a role for neprilysin in the regulation of beta-amyloid," said Verma, a Salk professor who is internationally recognized for his research on gene therapy. "It highlights the potential of using viral vectors for a gene therapy approach to treat, or perhaps prevent, Alzheimer's disease."

"What's significant about this is that neprilysin isn't a drug, but a molecule that controls levels of beta-amyloid naturally," said Gage, a Salk professor who has made important contributions to our understanding of Alzheimer's disease during the past decade. "This study is an example of how understanding the basic mechanisms of protein interaction can lead to new disease treatments."

Usually controlled by neprilysin, beta-amyloid exists in normal brains at far lower levels than seen in Alzheimer's disease. Its role in brain function is still in question, but scientists at the Salk Institute and other institutions suspect it plays important roles in transporting sub-cellular structures and molecules from one end of a nerve cell to another.

Alzheimer's disease is the most common form of dementia among older people. An estimated four million Americans suffer from the disease, which is marked by a progressive, severe loss of memory and ability to reason. Eventually, the disease progresses to the point that patients need 24-hour care. The disease' cause is unknown, but autopsy results clearly point to the accumulation of beta amyloid plaques and other abnormal structures called tangles in brain tissue.

The group is currently conducting mouse experiments to determine if neprilysin gene therapy results in any cognitive improvements in the mice. They are also investigating how the therapy works at different stages of the disease.



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Optimized Curcumin Longvida® Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Eating Fat is Good... Maybe... Could Be... Sometimes Eating Fat is Good... Maybe... Could Be... Sometimes
Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map